← FDA DRUG APPROVALS

FDA ANDA · ANDA076505

METRONIDAZOLE

Sponsor: ABLE

APPLICATION
ANDA076505
TYPE
ANDA
ORIGINAL APPROVAL
2003-11-13
LATEST ACTION
2005-03-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

METRONIDAZOLEDiscontinued
METRONIDAZOLE 375MG · CAPSULE · ORAL

Approval history

2005-03-28Labeling · Supplement 3AP
2003-12-16Labeling · Supplement 1AP
2003-11-13OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →